Masuk tirto.id
Jadikan tirto.id sumber pilihan pencarian Google
We are advised by Arkbio that journalists and other readers should disregard the news release, Ark Biopharmaceutical Receives China Marketing Authorization for Azstarys® for the Treatment of ADHD, issued on Jan. 6, 2026 by Arkbio over PR Newswire, as the release contained inappropriate information.
Sumber: www.prnasia.com
Disclaimer: This press release was supplied by a third party. Tirto is not involved in its preparation and bears no responsibility for its content.
Reporter: PR Newswire
Penulis: PR Newswire
Editor: PR Newswire
Penulis: PR Newswire
Editor: PR Newswire
